PRESS RELEASE

from CompuGroup Medical SE & Co. KGaA (isin : DE000A288904)

CGM plans to double its dividend

EQS-News: CompuGroup Medical SE & Co. KGaA / Key word(s): Dividend
CGM plans to double its dividend

20.02.2024 / 20:37 CET/CEST
The issuer is solely responsible for the content of this announcement.


CGM plans to double its dividend

Koblenz. The general partner of CompuGroup Medical SE & Co. KGaA (CGM) intends to sustainably increase the dividend to a higher level, and will therefore propose a dividend of EUR 1.00 per share to the Annual General Meeting for the financial year 2023. Based on the 52.2 million shares currently entitled to a dividend payment, the planned total payout would double to EUR 52.2 million (previous year: EUR 26.1 million). Based on the year-end closing price for 2023 (Xetra closing price on December 29, 2023: EUR 37.90), this proposal corresponds to a dividend yield of 2.6 percent.

“The resilience of our business model and the improved free cash flow profile enable us to sustainably increase the dividend level for our shareholders while at the same time continuing to invest into future growth“, comments Michael Rauch, CEO of CompuGroup Medical.

The preliminary figures for the financial year 2023 and the guidance for 2024 were already announced on February 7, 2024. The full annual report will be published on the company's website under the Investor Relations section on March 28, 2024. Based on the final financial results for the financial year, the general partner and the supervisory board will decide on their final dividend proposal to the general meeting.

 



20.02.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language:English
Company:CompuGroup Medical SE & Co. KGaA
Maria Trost 21
56070 Koblenz
Germany
Phone:+49 (0)160 3630362
Fax:+49 (0)261 8000 3200
E-mail:investor@cgm.com
Internet:www.cgm.com
ISIN:DE000A288904
WKN:A28890
Indices:SDAX, TecDAX
Listed:Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID:1841413

 
End of NewsEQS News Service

1841413  20.02.2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1841413&application_name=news&site_id=symex~~~af100301-a623-4c64-8f3d-90fc88eca9e6
See all CompuGroup Medical SE & Co. KGaA news